Webcast Hospira at Bank of America Merrill Lynch Health Care Conference (Replay) 05/16/12 at 8:40 a.m. PT

Hospira 2012 Annual Meeting Materials – New!
Hospira's 2012 annual meeting of shareholders will be held May 9, 2012. The 2012 Proxy Statement and 2011 Annual Report are now available for viewing online.  For voting information, click here.

Once again this year, we are providing our proxy materials online, with paper copies available upon request. By moving most of our proxy communications online, we significantly reduce the environmental impact of printing and mailing the proxy materials, as well as significantly reduce the printing, postage and distribution costs.

Shareholders of record as of March 12, 2012 will be receiving a Notice via U.S. mail in early April detailing the availability of Hospira's annual report, proxy statement and online proxy ballot on the Internet. The Notice will contain instructions on how to access the materials online.  For shareholders who prefer to receive traditional printed copies of the proxy materials, the Notice will include instructions on how to request the printed materials, free of charge.

We are proud to support the environment and Hospira's financial well-being and appreciate our shareholders' continued support of the company.

• Your vote is important

Shareholder E-Delivery
Are you a Hospira shareholder? If so, you can elect to receive your annual report, proxy statement and other investor-related materials online, reducing the amount of mailings you receive from us. Using Shareholder E-Delivery also promotes less paper usage, a more environmentally friendly practice, and helps reduce company costs. If this is an option that interests you, sign up today!

Corporate Profile
Hospira, Inc. is the world's leading provider of injectable drugs and infusion technologies. Through its broad, integrated portfolio, Hospira is uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. Headquartered north of Chicago in Lake Forest, Ill., Hospira has approximately 15,000 employees worldwide and generated approximately $4.1 billion in net sales in 2011.
To learn more, click here.